Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharmacyclics raising $57.1M in stock sale
Bizjournals.com
Friday, June 17, 2011 - 10:18am
tags:
stock offering, Pharmacyclics
When Two Cancer Drugs Are Better Than One
Bloomberg Businessweek
Friday, June 17, 2011 - 10:17am
tags:
Merck, AstraZeneca, Eli Lilly, Roche, GSK, Takeda, cancer, Bristol-Myers Squibb
UCB Reports Data on Neupro
Yahoo/Zacks.com
Friday, June 17, 2011 - 9:45am
tags:
UCB Pharmaceuticals, Neupro, restless legs syndrome
Analysis: Data may help Bristol/Pfizer clot drug catch rivals
CNBC
Friday, June 17, 2011 - 9:42am
tags:
Pfizer, blood thinners, Bristol-Myers Squibb, Apixaban, Boehringer Ingelheim, Pradaxa, JNJ, Xarelto, Bayer
10 Reasons to Own Gilead Sciences
Seeking Alpha
Friday, June 17, 2011 - 9:34am
tags:
Gilead Sciences
Regeneron shares halted; FDA looks at license bid
Marketwatch
Friday, June 17, 2011 - 9:33am
tags:
FDA, Regeneron, VEGF Trap-Eye
[video] The Next Big Thing In Biotech: Pain Therapeutics
TheStreet.com
Friday, June 17, 2011 - 9:32am
tags:
Pain Therapeutics, Remoxy
Eli Lilly Offers Remedies in EU Review of Janssen Deal
Bloomberg
Friday, June 17, 2011 - 9:30am
tags:
Eli Lilly, Europe, Janssen Pharmaceuticals
FDA committee to review Seattle Genetics cancer drug applications in July
bizjournals.com
Thursday, June 16, 2011 - 10:19pm
tags:
FDA, Seattle Genetics, brentuximab vedotin
J&J Fails to Win Appeal of U.K. Backing of Rival’s Thalidomide
Bloomberg
Thursday, June 16, 2011 - 10:17pm
tags:
JNJ, thalidomide, Celgene, Velcade
The “New Normal” at Johnson & Johnson
Barron's
Thursday, June 16, 2011 - 10:15pm
tags:
JNJ
Amgen, J&J Anemia Drugs Won’t Face New U.S. Coverage Policy
Bloomberg
Thursday, June 16, 2011 - 10:14pm
tags:
Amgen, JNJ, Epogen, Procrit, Aranesp, anemia
Are Two FDA Approvals in One Week a Positive Sign?
Motley Fool
Thursday, June 16, 2011 - 10:12pm
tags:
FDA, Nulojix, kidney transplant, Bristol-Myers Squibb, GSK, Valeant Pharmaceuticals, Potiga, epilepsy
Off a Cliff: $100 Billion in Revenues Will Disappear From Drug Business by 2013
BNET Pharma
Thursday, June 16, 2011 - 12:29pm
tags:
patents, generics, Pfizer, Eli Lilly, Bristol-Myers Squibb, GSK, Novartis, AstraZeneca, Merck, Sanofi, JNJ, Forest Labs
Analyst gives Pfizer advanced lung cancer drug 80 percent chance of receiving FDA approval
Yahoo/AP
Thursday, June 16, 2011 - 12:10pm
tags:
FDA, lung cancer, crizotinib
The FDA's Drug Approval Agenda for Next Week
Seeking Alpha
Thursday, June 16, 2011 - 11:42am
tags:
FDA, Xifaxan, Salix, IBS, Remoxy, Durect Corporation, Pain Therapeutics, Pfizer, painkillers
A Drugmaker, A Short Seller & A Citizen’s Petition
Pharmalot
Thursday, June 16, 2011 - 11:40am
tags:
FDA, Neoprobe, Lymphoseek
Sanofi hunts for drugs against hearing loss
Reuters
Thursday, June 16, 2011 - 11:33am
tags:
Sanofi, hearing loss, Audion
Cancer Vaccines and Oncothyreon: Flying Higher as Market Sinks
Seeking Alpha
Thursday, June 16, 2011 - 11:31am
tags:
Oncothyreon, vaccines, cancer, Biovest International, Antigenics, Dendreon, CytRx, ImmunoCellular, Keryx
Cytori Therapeutics and Its Publicly-Traded Outstanding Warrants: A Lesson on Leverage
Seeking Alpha
Thursday, June 16, 2011 - 11:29am
tags:
Cytori

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.